Key result
In patients with STEMI, chronic total occlusion was not independently associated with 1-year mortality (HR 1.07; 95% CI 0.66-1.73; p=0.78) after adjusting for ejection fraction and renal function.
Why the study?
Does the presence of chronic total occlusion (CTO) in a non-infarct-related artery impact 1-year mortality in STEMI patients undergoing primary PCI?
Observational (n=2,020)
No
Does the presence of chronic total occlusion (CTO) in a non-infarct-related artery impact 1-year mortality in STEMI patients undergoing primary PCI?
Answers are grounded in this paper and cite their sources.
OBJECTIVES: To investigate the predictors and impact on long-term survival of one chronic total occlusion (CTO) or multiple CTOs in patients presenting with ST-elevation myocardial infarction (STEMI). DESIGN: Single-centre retrospective observational study. SETTING: University-based tertiary referral centre. PATIENTS: Between 2006 and 2011, a total of 2020 consecutive patients referred with STEMI were categorised into single vessel disease, multivessel disease (MVD) without CTO, with one CTO or with multiple CTOs. INTERVENTION: Primary percutaneous coronary intervention. MAIN OUTCOME MEASURE: The primary end-point was the 1-year mortality. RESULTS: The prevalence of single vessel disease, MVD without CTO, with one CTO or with multiple CTOs was 70%, 22%, 7.2% and 0.8%, respectively. Independent clinical predictors for the presence of CTO were cardiogenic shock (OR 5.05; 95% CI 3.29 to 7.64), prior myocardial infarction (OR 2.06; 95% CI 1.35 to 3.09), age >65 years (OR 1.94; 95% CI 1.40 to 2.71) and history of angina (OR 1.94; 95% CI 1.29 to 2.87). Mortality was worse in patients with multiple CTOs (76.5%) compared with those with one CTO (28.1%) or without CTO (7.3%) (p<0.0001). After adjustment for left ventricular ejection fraction and renal function, MVD was an independent predictor for 1-year mortality (HR: 1.81; 95% CI 1.18 to 2.77, p=0.007), but CTO was not (HR: 1.07; 95% CI 0.66 to 1.73, p=0.78). CONCLUSIONS: Simple clinical factors are associated with the presence of CTO in non-infarct-related artery in patients presenting with STEMI. In these patients, long-term survival was independently associated with MVD, left ventricular ejection fraction and renal function, but not with CTO per se.
No takes yet. Share an insight, caveat, or question.
Bataille et al. (2012) conducted an observational in ST-elevation myocardial infarction (STEMI) (n=2,020). Chronic total occlusion (CTO) vs. No CTO was evaluated on 1-year mortality (HR 1.07, 95% CI 0.66-1.73, p=0.78). In patients with STEMI, chronic total occlusion was not independently associated with 1-year mortality (HR 1.07; 95% CI 0.66-1.73; p=0.78) after adjusting for ejection fraction and renal function.
Synapse has enriched 10 related papers. Consider them for comparative context: